Holly H. Gallion - Publications, H-index & Citations

Holly H. Gallion

University of Kentucky

46H指数

198论文数

6.5K被引数

收录论文 13

发表时间

Pharmacokinetics, bioavailability, and pharmacodynamics of oral triapine

CANCER RESEARCH

IF16.6

2023-04-04

PREAI

Beumer, Jan H.; Behr, Sarah; Gallion, Holly; Vargo, John; Ueland, Frederick; Mahdi, Haider; Orr, Brian; Girda, Eugenia; Christner, Susan; Chu, Edward; Kunos, Charles; Ivy, Percy S.; Taylor, Sarah

Next Generation Sequencing and Molecular Biomarkers in Ovarian Cancer-An Opportunity for Targeted Therapy 卵巢癌的下一代测序和分子生物标志物-靶向治疗的机会

DIAGNOSTICS

IF3.3

2022-03-29

OAAI

Harbin, Laura M.; Gallion, Holly H.; Allison, Derek B.; Kolesar, Jill M.

Significance of Pelvic Fluid Observed during Ovarian Cancer Screening with Transvaginal Sonogram

DIAGNOSTICS

IF3.3

2022-01-07

OAAI

Gorski, Justin W.; Dietrich, Charles S., III; Davis, Caeli; Erol, Lindsay; Dietrich, Hayley; Per, Nicholas J.; Ferrell, Emily Lenk; McDowell, Anthony B.; Riggs, McKayla J.; Hutchcraft, Megan L.; Baldwin-Branch, Lauren A.; Miller, Rachel W.; DeSimone, Christopher P.; Gallion, Holly H.; Ueland, Frederick R.; van Nagell, John R.; Pavlik, Edward J.

Utilizing Patient-Derived Epithelial Ovarian Cancer Tumor Organoids to Predict Carboplatin Resistance

BIOMEDICINES

IF3.9

2021-08-16

OAAI

Gorski, Justin W.; Zhang, Zhuwei; McCorkle, J. Robert; DeJohn, Jodi M.; Wang, Chi; Miller, Rachel W.; Gallion, Holly H.; Dietrich, Charles S.; Ueland, Frederick R.; Kolesar, Jill M.

MUTYH as an Emerging Predictive Biomarker in Ovarian Cancer

DIAGNOSTICS

IF3.3

2021-01-06

OAAI

Hutchcraft, Megan L.; Gallion, Holly H.; Kolesar, Jill M.

Disease-Specific Survival of Type I and Type II Epithelial Ovarian Cancers-Stage Challenges Categorical Assignments of Indolence & Aggressiveness

DIAGNOSTICS

IF3.3

2020-01-21

OAAI

Pavlik, Edward J.; Smith, Christopher; Dennis, Taylor S.; Harvey, Elizabeth; Huang, Bin; Chen, Quan; Piecoro, Dava West; Burgess, Brian T.; McDowell, Anthony; Gorski, Justin; Baldwin, Lauren A.; Miller, Rachel W.; DeSimone, Christopher P.; Dietrich, Charles, III; Gallion, Holly H.; Ueland, Frederick R.; van Nagell, John R., Jr.

Inherited alterations of Transforming Growth Factor Beta signaling components in Appalachian Cervical Cancers

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

IF3.4

2017-02-05

PREAI

Knobloch, Thomas J.; Oghumu, Steve; Sears, Marta; Zhang, Zhaoxia; Ogbemudia, Blessing; Perrault, Joe; Cohn, David; DeGraffinreid, Cecilia R.; Lu, Bo; Peng, Juan; Hade, Erinn M.; Schiano, Michael A.; Calhoun, Byron C.; Mcbee, William, Jr.; Lesnock, Jamie; Gallion, Holly; Pollock, Jondavid; Ruffin, Mack T.; Weghorst, Christopher M.; Paskett, Electra D.

Does the Progression-Free Interval After Primary Chemotherapy Predict Survival After Salvage Chemotherapy in Advanced and Recurrent Endometrial Cancer?

CANCER

IF5.1

2010-11-29

PREAI

Moore, Kathleen N.; Tian, Chunqiao; McMeekin, D. Scott; Thigpen, J. Tate; Randall, Marcus E.; Gallion, Holly H.

Chemotherapy Intensity and Toxicity Among Black and White Women With Advanced and Recurrent Endometrial Cancer A Gynecologic Oncology Group Study

CANCER

IF5.1

2009-11-18

OAAI

Farley, John H.; Tian, Chunqiao; Rose, G. Scott; Brown, Carol L.; Birrer, Michael; Risinger, John I.; Thigpen, J. Tate; Fleming, Gini F.; Gallion, Holly H.; Maxwell, G. Larry

Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinoma - A Gynecologic Oncology Group study

CANCER

IF5.1

2006-09-25

OAAI

Maxwell, G. Larry; Tian, Chunqiao; Risinger, John; Brown, Carol L.; Rose, G. Scott; Thigpen, J. Tate; Fleming, Gini F.; Gallion, Holly H.; Brewster, Wendy R.

Centrosome abnormalities in ovarian cancer 卵巢癌的中心体异常

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2004-12-08

OAAI

Hsu, LC; Kapali, M; DeLoia, JA; Gallion, HH

Phase III randomized trial of doxorubicin plus cisplatin versus doxorubicin+24-h paclitaxel plus filgrastim in endometrial carcinoma: a Gynecologic Oncology Group study

ANNALS OF ONCOLOGY

IF65.4

2004-08-01

148

OAAI